|
|
|
||||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||||||
|
|
||||||||||||||||||||||||||||||||||||||||
|
|
||||||||||||||||||||||||||||||||||||||||
|
References 1. National Institutes of Health Consensus Development Conference Statement. Osteoporosis Prevention, Diagnosis, and Therapy. March 27-29, 2000. Accessed 7 May 2002. 2. Moritsugu KP, Slater E, McGowan JA, et al. Report of the Surgeon General's Workshop on Osteoporosis and Bone Health; 2002 Dec 12-13;Washington, DC [report on the Internet]: U.S. Department of Health and Human Services (HHS); c2003. 3. By 2020, One In Two Americans Over Age 50 Will Be At Risk For Fractures From Osteoporosis Or Low Bone Mass. HHS Press Release 2004 October 14. 4. Americans Over 50 at Risk for Bone Fractures. FDA Consumer, Jan-Feb 2005;39(1):10-11. 5. Carmona RH. U.S. Dept. of HHS. Bone Health and Osteoporosis: A Report of the Surgeon General. Rockville, MD: U.S. Dept. of HHS, Office of the Surgeon General, revised: 12 Oct 2004. 6. National Osteoporosis Foundation: Osteoporosis: What is it? Washington, DC: National Osteoporosis Foundation. 7. Tebas P, Powderly WG, Claxton S, et al. Accelerated Bone Mineral Loss In HIV-infected Patients Receiving Potent Antiretroviral Therapy. AIDS 2000;14(4):F63-7. 8. Borderi M, Farneti B, Tampellini L, et al. HIV-1, HAART And Bone Metabolism. New Microbiol 2002;25(3):375-84. 9. Ries MD, Barcohana B, Davidson A, et al. Association Between Human Immunodeficiency Virus and Osteonecrosis of the Femoral Head. J Arthroplasty 2002;17(2):135-139. 10. Thomas J, Doherty SM. HIV infection: A Risk Factor For Osteoporosis. J Acquir Immune Defic Syndr 2003;33(3):281-91. 11. Brown TT, Ruppe MD, Kassner R, et al. Reduced Bone Mineral Density In Human Immunodeficiency Virus-Infected Patients And Its Association With Increased Central Adiposity And Postload Hyperglycemia. J Clin Endocrinol Metab 2004;89(3):1200-6. 12. Miller KD, Masur H, Jones EC, et al. High Prevalence Of Osteonecrosis Of The Femoral Head In HIV-Infected Adults. Annals Internal Med 2002;137(1):17-25. 13. Madeddu G, Spanu A, Solinas P, et al. Bone Mass Loss And Vitamin D Metabolism Impairment In HIV Patients Receiving Highly Active Antiretroviral Therapy. Q J Nucl Med Mol Imaging 2004;48(1):39-48. 14. Qaqish RB, Sims KA. Bone Disorders Associated With The Human Immunodeficiency Virus: Pathogenesis And Management. Pharmacotherapy 2004;24(10):1331-46. 15. Miller MG, Mulligan T. Human Immunodeficiency Virus And Hypogonadal Bone Disease. Pharmacotherapy 2005;25(4):632-4; discussion 634. 16. Heap J, Murray MA, et al. Alterations In Bone Characteristics Associated With Glycemic Control In Adolescents With Type 1 Diabetes Mellitus. J Pediatr 2004;144(1):56-62. 17. Piepkorn B, Kann P, Forst T, et al. Bone Mineral Density And Bone Metabolism In Diabetes Mellitus. Horm Metab Res 1997;29(11):584-91. 18. Wang J, Zhou J, Cheng CM, et al. Evidence Supporting Dual, IGF-I-Independent And IGF-I-Dependent, Roles For GH In Promoting Longitudinal Bone Growth. J Endocrinol 2004;180(2):247-55. 19. O'Conner DJ. Building Better Bones. Thorne Research, Inc., 1997. Accessed 7 May 2000. 20. Tinnerello D. Bone Health and Osteoporosis. Accessed 7 May 2000. 21. Holick MF. Vitamin D: importance In The Prevention Of Cancers, Type 1 Diabetes, Heart Disease, And Osteoporosis. Am J Clin Nutr 2004;79(3):362-71. 22. Nutrition
News Focus Electronic Listserv message. Accessed 26 July 2005.
|
||||||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||||||